← Back to all trials
Enrolling By Invitation
NCT06067893
Low Dose Dexmedetomidine as a Postoperative Pain Adjunct
Conditions: Spinal Fusion, Adolescent Idiopathic Scoliosis
Sex: All
Ages: 10 Years – 21 Years
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 46
Sponsor: Nichole Doyle
Location: Children's Mercy Hospital Kansas City Missouri
Summary
This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of idiopathic scoliosis
* Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement
Exclusion Criteria:
* Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively
* Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids
* Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin)
* Moya Moya disease
Source: ClinicalTrials.gov (NCT06067893). StuddyBuddy aggregates publicly available trial information.